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The transgenomic metabolic effects of exposure to either Lactobacillus paracasei or Lactobacillus
rhamnosus probiotics have been measured and mapped in humanized extended genome mice
(germ-free mice colonized with human baby ﬂora). Statistical analysis of the compartmental
ﬂuctuations in diverse metabolic compartments, including bioﬂuids, tissue and cecal short-chain
fatty acids (SCFAs) in relation to microbial population modulation generated a novel top-down
systems biology view of the host response to probiotic intervention. Probiotic exposure exerted
microbiome modiﬁcation and resulted in altered hepatic lipid metabolism coupled with lowered
plasma lipoprotein levels and apparent stimulated glycolysis. Probiotic treatments also altered a
diverse range of pathways outcomes, including amino-acid metabolism, methylamines and SCFAs.
The novel application of hierarchical-principal component analysis allowed visualization of
multicompartmental transgenomic metabolic interactions that could also be resolved at the
compartment and pathway level. These integrated system investigations demonstrate the potential
ofmetabolicproﬁlingasatop-downsystemsbiologydriverforinvestigatingthemechanisticbasisof
probiotic action and the therapeutic surveillance of the gut microbial activity related to dietary
supplementation of probiotics.
Molecular Systems Biology 15 January 2008; doi:10.1038/msb4100190
Subject Categories: metabolic and regulatory networks; microbiology and pathogens
Keywords: metabonomics; microbiome; NMR spectroscopy; probiotics; UPLC-MS
This is an open-access article distributed under the terms of the Creative Commons Attribution Licence,
which permits distribution and reproduction in any medium, provided the original author and source are
credited.Creationofderivativeworksispermittedbuttheresultingworkmaybedistributedonlyunderthe
same or similar licence to this one. This licence does not permit commercial exploitation without speciﬁc
permission.
Introduction
The gut microbiome–mammalian ‘Superorganism’ (Leder-
berg, 2000) represents a level of biological evolutionary
development in which there is extensive ‘transgenomic’
modulation of metabolism and physiology that is a character-
istic of true symbiosis. By deﬁnition, superorganisms contain
multiplecell types,and thecoevolvedinteracting genomes can
only be effectively studied as an in vivo unit in situ using top-
down systems biology approaches (Nicholson, 2006; Martin
et al, 2007a). Interest in the impact of gut microbial activity on
human health is expanding rapidly and many mammalian–
microbial associations, both positive and negative, have been
reported (Dunne, 2001; Verdu et al, 2004; Nicholson et al,
2005; Gill et al, 2006; Ley et al, 2006). Mammalian–microbial
symbiosis can play a strong role in the metabolism of
endogenous and exogenous compounds and can also be
inﬂuentialintheetiologyanddevelopmentofseveraldiseases,
for example insulin resistance (Dumas et al, 2006), Crohn’s
disease (Gupta et al, 2000; Marchesi et al, 2007), irritable
bowel syndrome (Sartor, 2004; Martin et al, 2006), food
allergies (Bjorksten et al, 2001), gastritis and peptic ulcers
(Warren, 2000; Marshall, 2003), obesity (Ley et al, 2006;
Turnbaugh et al, 2006), cardiovascular disease (Pereira and
Gibson, 2002) and gastrointestinal cancers (Dunne, 2001).
Activities of the diverse gut microbiota can be highly speciﬁc
andithasbeenreportedthattheestablishmentofBiﬁdobacteria
is important for the development of the immune system and
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Salminen et al, 2005; Ouwehand, 2007). In particular, elevated
counts in Biﬁdobacterium with reduced Escherichia coli,
streptococci, Bacteroides and clostridia counts in breast-fed
babies compared to formula-fed neonates may result in the
lower incidence of infections, morbidity and mortality in
breast-fed infants (Dai et al, 2000; Kunz et al, 2000). As the
microbiome interacts strongly with the host to determine the
metabolicphenotype(HolmesandNicholson,2005;Gavaghan
McKee et al, 2006) and metabolic phenotype inﬂuences
outcomesofdruginterventions(Nicholsonetal,2004;Clayton
et al, 2006), thereis clearly an important role of understanding
these interactions as part of personalized healthcare solutions
(Nicholson, 2006).
One of the current approaches used to modulate the balance
of intestinal microﬂora is based on oral administration of
probiotics. A probiotic is generally deﬁned as a ‘live microbial
feed supplement which beneﬁcially affects the host animal by
improving its intestinal microbial balance’ (Fuller, 2004). The
gastrointestinal system is populated by potentially pathogenic
bacteria that are capable of degrading proteins (putrefaction),
releasing ammonia, amines and indoles, which in high
concentrations can be toxic to humans (Cummings and
Bingham, 1987). Probiotic supplementation aims at replacing
or reducing the number of potentially harmful E. coli and
Clostridia in the intestine by enriching the populations of gut
microbiota that ferment carbohydrates and that have little
proteolytic activity. Probiotics, most commonly Lactobacillus
and Biﬁdobacteria, can be used to modulate the balance of the
intestinal microﬂora in a beneﬁcial way (Collins and Gibson,
1999). Although Lactobacilli do not predominate among the
intestinal microﬂora, their resistance to acid conditions and
bile salts toxicity results in their ubiquitous presence through-
out the gut (Corcoran et al, 2005), hence they can exert
metabolic effects at many levels. Fermented dairy products
containing Lactobacillus have traditionally been used to
modulate the microbial ecology (Dunne, 2001). In particular,
L. paracasei was shown to modulate the intestinal physiology,
to prevent infection of pathogenic bacteria (Sarker et al, 2005),
to stimulate the immune system (Ibnou-Zekri et al, 2003), and
to normalize gastrointestinal disorders (Martin et al, 2006).
L. rhamnosus is also a signiﬁcant probiotic strain with proven
healthbeneﬁtsandtherapeuticapplicationsinthetreatmentof
diarrhea (Szynanski et al, 2006), irritable bowel syndrome
(Kajander et al, 2005), atopic eczema (Corcoran et al, 2005)
and the prevention of urinary tract infections (Reid and Bruce,
2006). However, the functional effects of probiotic interven-
tions cannot be fully assessed without probing the biochem-
istry of the host at multiple compartmental levels, and we
propose that top-down systems biology provides an ideal
approachtofurtherunderstandinginthisﬁeld.Themicrobiota
observed in human baby ﬂora (HBF) mice have a number of
similarities with that found in formula-fed neonates (Mackie
etal,1999),whichmakesittobeawell-adaptedandsimpliﬁed
model to assess probiotics impact on gut microbial functional
ecosystems (in particular on metabolism of Biﬁdobacteria
and potential pathogens) and subsequent effects on host
metabolism.
Metabolic proﬁling using high-density data generating
spectroscopic techniques, in combination with multivariate
mathematical modelling is a tool which is well suited to
generate metabolic proﬁles that encapsulate the top-down
system response of an organism to a stressor or intervention
(Nicholson and Wilson, 2003). Multivariate metabolic proﬁl-
ing offers a practical approach to measuring the metabolic
endpointsthatlinkdirectly towholesystemactivityandwhich
aredeterminedbybothhostgeneticandenvironmentalfactors
(Nicholsonetal,2005).Recently,metabolicproﬁlingstrategies
have been successfully applied to characterizing the metabolic
consequences of nutritional intervention (Rezzi et al, 2007;
Wang et al, 2007) the effects of the gut microﬂora on
mammalian metabolism (Martin et al, 2006, 2007a,b) and
mechanisms of insulin-resistance (Dumas et al, 2006). In the
current study,
1H nuclear magnetic resonance (NMR) spectro-
scopy and targeted ultra performance liquid chromatography-
mass spectrometry (UPLC-MS) analysis have been applied to
characterize the global metabolic responses of humanized
microbiome mice subsequently exposed to placebo, Lactoba-
cillus paracasei or Lactobacillus rhamnosus supplementation.
Correlation of the response across multiple bioﬂuids and
tissue, using plasma, urine, fecal extracts, liver tissues and
ileal ﬂushes as the biological matrices for the detection of
dietary intervention, generates a top-down systems biology
view of the response to probiotics intervention.
Results
Gut bacterial composition
Microbiological analyses were performed on fecal samples to
assessthegrowthoftheHBFingerm-freemiceandtoascertain
the effects of probiotics on the development of gut bacteria.
The measured terminal composition of the fecal microbiota is
detailedinTableI,wherethestatisticallysigniﬁcantdifferences
between the various groups were calculated using a two-
tailed Mann–Whitney test. The bacterial populations of
Biﬁdobacterialongumand Staphylococcusaureus were reduced
after introduction of both probiotics. Additionally, unique
effects of L. rhamnosus supplementation caused decreased
populations of Biﬁdobacterium breve, Staphylococcus epidermi-
dis and Clostridium perfringens but an increase of E. coli.
Gut levels of short-chain fatty acids
Short-chain fatty acids (SCFAs), namely acetate, propionate,
isobutyrate, n-butyrate and isovalerate, were identiﬁed and
quantiﬁed from the cecal content using GC-FID. The results,
presented in Table II, are given in mmol per gram of dry fecal
material and as mean±s.d. for each group of mice. The
production of some of the SCFAs, that is, acetate and butyrate,
by the HBF mice supplemented with both of the probiotics
was reduced. In addition, increases of the concentrations in
isobutyrate and isovalerate were observed in the mice fed with
L. paracasei.
Analysis of
1H NMR spectroscopic data on plasma,
urine, liver and fecal extracts
A series of pairwise O-PLS-DA models of
1H NMR spectrawere
performed to extract information on the metabolic effects of
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phenotype separation between untreated mice and probiotic
supplemented animals was observed as reﬂected by the
high value of QY
2 for each model (Cloarec et al, 2005b; Table
III). The corresponding coefﬁcients describing the most
important metabolites in plasma, liver, urine and fecal extracts
that contributed to group separation are also listed in
Supplementary Table 1. The area normalized intensities
(10
1a.u.) of representative metabolite signals are given as
means±s.d. in Table III. The O-PLS-DA coefﬁcients plots are
presented in Figure 1 using a back-scaling transformation and
projection to aid biomarker visualization (Cloarec et al,
2005b). The direction of the signals in the plots relative to
zero indicates positive or negative covariance with the
probiotic-treated class. Each variable is plotted with a color
code that indicates its discriminating power as calculated from
the correlation matrix thus highlighting biomarker-rich
spectral regions.
Liver metabolic proﬁles
Livers of mice fed with L. paracasei showed relative decreases
in dimethylamine (DMA), trimethylamine (TMA), leucine,
isoleucine, glutamine, and glycogen and increased levels of
succinate and lactate (Figure 1A). Mice supplemented with
L. rhamnosus showed relative decreases in leucine and
isoleucine and relative increases in succinate, TMA and
trimethylamine-N-oxide (TMAO) in the liver compared to
controls (Figure 1D).
Plasma metabolic proﬁles
Plasma samples showed relative decreases in the levels of
lipoproteins and increases in the concentrations of glycero-
phosphorylcholine (GPC) and triglycerides in mice fed with
both probiotics compared to controls (Figure 1B and E).
Elevated choline levels were observed in plasma of mice fed
with L. rhamnosus and reduced plasma citrate levels were
observed in mice fed with L. paracasei compared to controls.
Fecal extract metabolic proﬁles
Marked changes were observed in the metabolic proﬁles of
fecal extractsfrom all supplementedmice, forexamplerelative
decreased concentrations of choline, acetate, ethanol, a range
of putative N-acetylated metabolites (NAMs), unconjugated
bileacids(BAs)andtauro-conjugatedbileacids(Figure1Cand
F). Furthermore, relative higher levels of glucose, lysine and
polysaccharides were detected in the feces from mice fed with
probiotics. A relative increased level of n-caproate (chemical
shifts d at 0.89(t), 1.27(m), 1.63(q), 2.34(t)) appeared to be
associated with mice supplemented with L. paracasei.
Urine metabolic proﬁles
Urine samples of mice supplemented with both probiotics
showed relative increased concentrations of indoleacetylgly-
cine (IAG), phenylacetylglycine (PAG), tryptamine and a
relative decrease in the levels of a-keto-isocaproate and citrate
(Figure 1G and H). Relative increased concentrations of a
mixture of putative glycolipids (UGLp, chemical shifts of
multiplets at d 0.89, 1.27, 1.56, 1.68, 2.15, 2.25, 3.10, 3.55,
3.60), N-acetyl-glycoproteins (NAGs) and a reduction in
3-hydroxy-isovalerate were also observed in mice supplemen-
ted with L. paracasei compared to controls. Urine of mice fed
withL.rhamnosusshowedareductioninlevelsofcreatineand
citrulline.
Table II Short-chain fatty acid content in the cecum from the different groups
Amounts of SCFAs given in mmol per gram of dry
feces for each group
Acetate Propionate Isobutyrate Butyrate Isovalerate
HBF (n=10) 77.6±17.6 22.3±4.3 0.9±0.2 3±0.6 2.1±0.6
HBF+L. paracasei (n=9) 52.3±23.6*** 22.2±10.8 1.2±0.5*** 1.5±0.8*** 2.7±1.2**
HBF+L. rhamnosus (n=9) 40.6±8*** 20.3±2.8 0.8±0.2 2.1±0.4*** 2.1±0.5
Data are presented in mmol per gram of dry feces and are presented as means±s.d. The amounts of SCFAs for the HBF mice supplemented with probiotics were
compared to HBF control mice, ** and *** indicate a signiﬁcant difference at 99 and 99.9% conﬁdence levels, respectively.
Table I Microbial species counts in mouse feces at the end of the experiment
Groups/log10 CFU HBF (n=10) HBF+L. paracasei (n=9) HBF+L. rhamnosus (n=9)
L. paracasei — 8.5±0.2 —
L. rhamnosus — — 7.8±0.2
E. coli 9.2±0.3 9.4±0.3 9.8±0.5**
B. breve 9.1±0.2 7.78±2.13 8.7±0.3*
B. longum 8.2±0.6 5.6±1.9*** 6.3±0.5***
S. aureus 7.4±0.3 6.3±0.3*** 6.6±0.5***
S. epidermidis 4.8±0.4 4.9±1.2 4.0±0.5**
C. perfringens 7.2±0.3 7.0±0.5 5.7±1.0***
Bacteroides 10.3±0.2 10.4±0.2 10.1±0.4
log10 CFU (colony-forming unit) given per gram of wet weight of feces. Data are presented as mean±s.d. Absence of speciﬁc bacterial strains in the gut microﬂora is
indicated by ‘‘—’’. The values for the HBF mice supplemented with probiotics were compared to HBF control mice, *
, ** and *** indicate a signiﬁcant difference at 95,
99 and 99.9% conﬁdence levels, respectively.
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The proportion of bile acids in ileal ﬂushes from the different
groups are given in Table IV and are shown as mean±s.d. of
the percentage of the total bile acid content. O-PLS-DA of the
data set revealed that the relative concentrations of bile acids
obtained from unsupplemented HBF mice are separated from
those treated with probiotics, the correlation observed with
L. paracasei being more signiﬁcant than with L. rhamnosus as
noted by the values of the cross-validated model parameter QY
2
(Figure 2). For example, HBF mice supplemented with
L. paracasei showed strong correlations with higher amounts
of GCA, CDCA and UDCA and lower levels of a-MCA in the
ileal ﬂushes when compared to controls. HBF mice fed with
L. rhamnosus also showed higher levels of GCA associated
with lower levels of TUDCA and TCDCA in the ileal ﬂushes
when compared to untreated HBF mice.
Integration of multicompartment metabolic data
using hierarchical-principal component analysis
A principal component analysis (PCA) model was initially
constructed separately for the metabolic data from each
individualbiologicalmatrix(plasma,urine,liver,fecalextracts
andbileacidcompositioninilealﬂush; Figures3and4).Three
principal components were calculated for each cross-validated
PCA model, except for the plasma where four principal
componentswereretainedtomaximizetheexplainedvariance
R
2X and the cross-validation parameter Q
2 following the
standard sevenfold cross-validation method (Cloarec et al,
2005b). These PCA models descriptors (R
2X/Q
2) were 0.70/
0.36 (plasma), 0.41/0.11 (urine), 0.80/0.71 (liver), 0.94/0.67
(bile acid) and 0.61/0.42 (feces). The score vectors tb from
each model were then assigned as new X-variables (Figure 3).
Thus, the top level X-matrix contained 16 descriptors, denoted
Table III Summary of inﬂuential metabolites for discriminating NMR spectra of liver, plasma, fecal extracts and urine
Metabolites Chemical shift and multiplicity HBF controls HBF+L. paracsei HBF+L. rhamnosus
Liver QY
2=21%, RX
2=44% QY
2=41%, RX
2=37%
Leu 0.92(t) 2.4±0.6 1.7±0.3*** 1.9±0.5*
Ileu 0.94 (t) 0.8±0.1 0.6±0.05*** 0.7±0.2
Lactate 1.32(d) 38.4±5.8 46.2±8.2
a 39.2±9.7
Succinate 2.41(s) 0.2±0.1 1.0±0.6** 0.7±0.3*
MA 2.61(s) 0.1±0.06 0.04±0.002** 0.08±0.05
TMA 2.91 (s) 0.2±0.04 0.07±0.03*** 0.2±0.09
TMAO 3.27(s) 10.3±2.2 13.1±3.7 18.5±8.0**
Gln 2.44(m) 0.4±0.1 0.3±0.1* 0.3±0.1
Glycogen 5.38–5.45 3.4±1.9 1.5±0.6* 3.2±1.9
Plasma QY
2=44%, RX
2=50% QY
2=51%, RX
2=32%
Lipoproteins 0.84 (m) 13.7±1.8 10.1±0.9*** 9.8±4.2**
Citrate 2.65(d) 1.4±0.3 0.9±0.4** 1.1±0.2**
Choline 3.2(s) 11.6±2.6 16.2±5.7* 20.5±3.8***
GPC 3.22(s) 44.1±4.6 57.3±12.5** 68.1±11.2***
Glyceryls 3.91(m) 2.0±0.3 2.5±0.4** 2.7±0.4**
Feces QY
2=90%, RX
2=48% QY
2=89%, RX
2=49%
Caprylate 1.27(m) 2.5±0.1 3.5±0.2*** 2.4±0.1
Lys 3.00(m) 3.2±0.8 5.0±0.3*** 4.9±1.2**
Osides 5.42(m) 0.9±0.09 1.2±0.1*** 1.4±0.1***
Bile acids 0.72(s) 3.1±0.9 1.8±0.7** 2.0±0.6*
Ethanol 1.18(t) 2.5±0.1 2.0±0.08*** 1.9±0.09***
Choline 3.20(s) 48.0±19.5 11.3±4.1*** 20.3±10.9***
NAM 2.06(m) 7.1±1.0 5.4±0.3*** 5.5±0.3***
Acetate 1.91(s) 58.7±34.2 27.0±9.2** 32.9±12.9*
U1 3.71(s) 9.2±0.5 7.3±0.3*** 8.2±0.5***
Urine QY
2=91%, RX
2=47% QY
2=59%, RX
2=46%
IAG 7.55(d) 0.1±0.03 0.6±0.2*** 0.4±0.2**
PAG 7.37(m) 0.8±0.1 1.5±0.3*** 1.2±0.4*
Tryptamine 7.70(d) 0.1±0.04 0.4±0.1*** 0.2±0.1**
UGLp 1.27(m) 1.7±0.1 2.7±0.4*** 1.7±0.2
Glycero-metabolites 4.04 (m) 1.7±0.1 2.2±0.2*** 1.9±0.2*
NAG 2.04(s) 3.5±0.2 4.3±0.2*** 3.8±0.5
Butyrate 0.90(t) 6.9±0.8 5.2±0.7** 5.2±0.9**
a-keto-isocaproate 0.94(d) 13.8±4.6 6.1±2.3** 7.9±2.1**
Propionate 1.05(t) 0.9±0.2 0.8±0.04* 0.8±0.1
3-hydroxy-isovalerate 1.24(s) 3.0±0.4 2.1±0.4** 2.6±0.2
Citrate 2.55(d) 10.8±7.6 1.6±0.6** 2.2±0.9*
Creatine 3.92(s) 5.7±2.1 4.5±1.5 3.5±0.3**
Citrulline 1.88(m) 3.8±0.5 3.3±0.4 3.0±0.4**
O-PLS models were generated for comparing probiotics treated to HBF control mice using one predictive and two orthogonal components, RX
2 value shows how
much of the variation is explained, QY
2 value represents the predictability of the models, and relates to its statistical validity. Data are presented as area normalized
intensities (10
1a.u.) of representative metabolite signals as means±s.d. The values for the HBF mice supplemented with probiotics were compared to HBF control
mice,
a, *
, ** and *** indicate a signiﬁcant difference at 90, 95, 99 and 99.9% conﬁdence levels, respectively.
s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublets. For metabolite abbreviations, refer to the key in Figure 1, MA: methylamine.
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(bileacidPCs1–3)andFi(fecalPCs1–3),whichcompriseonly
the systematic variation from each of the blocks/compart-
ments. The two ﬁrst principal components (p1 and p2)
calculated for the hierarchical-principal component analysis
(H-PCA; Westerhuis et al, 1998) model (R
2X¼0.60) accounted
for 37 and 23% of the total variance in the combined multi
compartment data respectively. The cross validation for the
H-PCA model failed due to the high degree of orthogonality
withintheX-matrix,thatis,withineachoftheblocksallvariables
Figure1 O-PLS-DAcoefﬁcientplotsderivedfrom
1HMASNMRCPMGspectraofliver(A,D),
1HNMRCPMGspectraofplasma(B,E),
1HNMRstandardspectraof
fecal extracts (C, F) and urine (G, H), indicating discrimination between HBF mice fed with probiotics (positive) and HBF control mice (negative). The color code
corresponds to the correlation coefﬁcients of the variables with the classes. BAs, Bile acids; DMA, dimethylamine; Glc, glucose; Gln, glutamine; GPC,
glycerophosphorylcholine; IAG, indoleacetylglycine; Ileu, isoleucine; Leu, leucine; Lys, lysine; NAG, N-acetylated glycoproteins; NAM, N-acetylated metabolites;
Osides, glycosides; PAG, phenylacetylglycine; TBAs, taurine conjugated to bile acids; TMA, trimethylamine; TMAO, trimethylamine-N-oxide; UGLp, unidentiﬁed
glycolipids.
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could be cross-validated at the individual level.
The H-PCA scores plot illustrated a degree of clustering with
respect to the groups of HBF mice (Figure 4A). The
corresponding H-PCA loadings plot indicated the contribution
of the 16 descriptors to the differences observed between the
samples in the H-PCA scores plot. Probiotic-supplemented
HBF animals are separated from the controls along the ﬁrst
principal component, and this arises from the main variations
modelled at the base level PCA of the individual plasma (P1,
P2), liver (L2, L3), ileal ﬂush (B2) and urine (U1, U2) data sets
(Figure 4B). HBF mice fed with L. paracasei were separated
from those fed with L. rhamnosus along the second principal
component, which was mainly due to the variations modelled
at the base level PCA of plasma (P2, P3), liver (L1) and urine
(U1, U3). Interestingly, the metabolic variations in the fecal
samples have no weight in discriminating the bacterial
supplementationfromthecorrespondingcontrolsintheglobal
model.
To uncover variables contributing to the H-PCA super
scores, the loadings at the base level PCA model were
interrogated (Figure 4C–F). HBF mice supplemented with
probiotics showed higher concentrations of glucose, choline,
GPC, glutamine, glutamate and lysine in the plasma proﬁles
associated with elevated concentrations of glucose in the liver
and higher levels of TUDCA and TCDCA in the ileal ﬂushes.
Controls showed higher levels of lipoproteins in the plasma,
elevated concentrations of lipids, glycogen, glutamine, gluta-
mate, alanine, TMAO and lactate in the liver, associated with
higher levels of TCA and TbMCA in the ileal content.
Unsupplemented HBF mice also showed elevated urinary
excretions of creatine, citrate, citrulline, lysine, UGLp, NAG
and a-keto-isocaproate compared to animals fed with probio-
tics. Moreover, H-PCA also revealed that HBF mice treated
with L. rhamnosus had higher levels of hepatic lipids and
plasma lipoproteins but lower concentrations of lactate and
amino acids in plasma and lower urinary excretion of PAG,
IAG, tryptamine and taurine than HBF mice treated with
L. paracasei.
Integration of correlations between bile acids and
fecal ﬂora
We further investigated the connections between fecal ﬂora
and intestinal bile acids using a correlation analysis based
bipartite graphical modelling approach (see Materials and
methods; Figure5) used previously to investigate the effects of
gut microbiome humanization in germfree mice (Martin et al,
2007a). In the current study, we are working with a superior
Table IV Bile acids composition in gut ﬂushes for the different microbiota
Microbiota/
Bile acids
HBF HBF+L. paracasei HBF+L. rhamnosus
CDCA ND 0.04±0.07 0.01±0.02
UDCA ND 0.1±0.1 ND
CA 0.4±0.5 0.3±0.7 0.3±0.2
oMCA ND 0.02±0.07 ND
aMCA 0.3±0.2 0.3±0.6 0.2±0.2
bMCA 0.9±0.7 1.3±2.7 0.8±0.7
GCA ND 0.1±0.1 0.1±.08
TCDCA 3.3±14 ±2.1 2.5±1.3
TUDC A 6.6±1.4 6.6±5.2 5.1±1.02
TbMCA 50±4.8 49.2±7.5 50.5±5.2
TCA 38±3.5 38±6.2 40.4±5
Relative composition in bile acids given in percentage of total bile acid content.
Species not detected with UPLC-MS experiment are shown as ND. The key is
given in UPLC-MS material and methods.
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which was not possible when considering conventional
microﬂora. Positive and negative correlations show the multi-
colinearity between bile acids and gut bacteria, whose
concentrations are interdependent such as in the case of
substrate–product biochemical reactions. Additional pixel
maps of the correlation matrices are given to help interpreta-
tion in Supplementary Figure 1.
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probiotics show remarkably different bile acid/fecal ﬂora
correlation networks (Figure 5A–C), indicating that small
modulations inthe speciescomposition ofthemicrobiomecan
result in major functional ecological consequences. Network
statisticsrevealthat microbiome/metabolomebipartite graphs
from HBF mice supplemented with Lactobacilli show a totally
different nodal structure (given for the cut-off value of 0.5). In
particular, we observed that in the network obtained from
control HBF mice, the most connected bacteria are Biﬁdobac-
teria, Staphylococci, and Clostridia, for which the variations
are intrinsically correlated with the balance in tauro-conju-
gated bile acids (TCDCA, TbMCA, TCA, TUDCA) and uncon-
jugated bile acids (CA, aMCA, bMCA). In particular, the
potentially harmful opportunist C. perfringens shows func-
tional correlation of opposite sign for TbMCA, TCDCA, aMCA
and bMCA when compared to Biﬁdobacteria and S. aureus.
Network analysis for HBF mice supplemented with
L. paracasei reveals that Lactobacilli supplementation resulted
in decreasing the functional links between Biﬁdobacteria and
bile acids, while new signiﬁcant correlations were observed
between bile acids, and Bacteroides, S. aureus, S. epidermidis
and L. paracasei. Moreover, E. coli has several connections
with UDCA, aMCA and TCDCA. Interestingly, Bacteroides
shows functional correlations of opposite signs for TbMCA,
TUDCA and TCA when compared to Lactobacilli and
Staphylococci.
When HBF mice received L. rhamnosus probiotic, the
microbiome/metabolome network shows a signiﬁcant lower
level of complexity (given for the cut-off value of 0.5). The
balance within B. breve, S. aureus and S. epidermidis appears
highly correlated to the composition in tauro-conjugated
bile acids (TbMCA, TCA) and unconjugated bile acids
(bMCA, CA).
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Figure 5 Integration of bile acid and fecal ﬂora correlations. The bipartite graphs were derived from correlations between fecal ﬂora and bile acids in each group: HBF
mice (A), HBF mice supplemented with L. paracasei (B)o rL. rhamnosus (C). The cut-off value of 0.5 was applied to the absolute value of the coefﬁcient |r| for
displaying the correlations between fecal ﬂora and bile acids. Bile acids and fecal bacteria correspond to blue ellipse nodes and green rectangle nodes, respectively.
Edges are coded according to correlation value: positive and negative correlations are respectively displayed in blue and in red. aMA, a-muricholic acid; Ba,
Bacteroides; Bb, B. breve; Bl, B. longum; bMA, b-muricholic acid; CA, cholic acid; CDCA, chenodeoxycholic acid; Cp, C. perfringens; Ec, E. coli; GCA,
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respectively.
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The cometabolic processes regulating mammalian systems
and their coexisting gut microbiota are an essential evolu-
tionary driver towards providing more reﬁned control me-
chanisms on the host physiology (Pereira and Gibson, 2002;
Pereiraetal,2003;Backhedetal,2004;HolmesandNicholson,
2005; Nicholson et al, 2005; Dumas et al, 2006; Martin et al,
2006, 2007a). In the present study, we demonstrate a
signiﬁcant association between the probiotic modulation of
the gut microbiome and the metabolism of SCFAs,amino acids
and methylamines, bile acids and plasma lipoproteins, and
also an association with stimulated glycolysis, showing the
remarkable diversity of symbiotic cometabolic connections.
Gut microbiotal links to host energy metabolism
We have recently described that HBF mice supplemented with
L. paracasei were characterized by a high gut content of tauro-
conjugated bile acids due to the inability of gut ﬂora to
deconjugate the bile acids, which resulted in high intestinal
absorption of dietary lipids, accumulation of lipids in the liver
and reduction of lipoprotein levels in plasma when compared
to conventional animals (Martin et al, 2007a). Here, we show
that probiotics supplementation of HBF mice resulted in a
decrease in the plasma concentrations of VLDL and low-
density lipoproteins (LDL) and increased triglyceride and GPC
concentrations in plasma when compared to HBF controls
(Figure 1B). In addition, the Lactobacillus supplementation
resulted in decreased fecal excretion of bile acids (Figure 1C),
that may be caused by accumulation of bile acids in
Lactobacillus probiotics (Kurdi et al, 2000). These observation
indicated probiotic-induced changes in the enterohepatic
recirculation of bile acids, which were shown to lower
cholesterol and systemic levels of blood lipids (Pereira and
Gibson, 2002). Moreover, probiotic-speciﬁc modulation of the
ileal concentrations of UDCA and CDCA (Figure 2; Table IV)
may also contribute to modulation of the synthesis and
secretion of VLDL into the blood (Lin et al, 1996; Watanabe
et al, 2004).
Moreover, the main source of dietary lipids in animal chow
is soybean oil, which is composed at 65% of long-chain
polyunsaturated fatty acids.It is well known that Lactobacillus
hydrolyzes soy oil to conjugated linoleic acid efﬁciently (Xu
et al, 2005), which results in a reduction of plasma lipoprotein
concentrationsandhepaticcholesterol(Fukushimaetal,1996,
1997; Al-Othman, 2000) and in the inhibition of S. aureus
growth (Das, 2002), as observed in the current study.
Furthermore, probiotics supplementation was associated with
signiﬁcant reduction of acetate in the cecal content (Table II)
and in a reduced hepatic acetate:propionate ratio, for which a
serum lipids lowering effect has previously been described
(Wong et al, 2006). Our results illustrate the ﬁne relationship
between a speciﬁc gut microbial population modulation and
the host’s lipid metabolism and that a probiotic intervention
can provide reﬁned control mechanisms on the host’s
physiology.
Furthermore, the molecular foundations of beneﬁcial
symbiotic host–bacteria relationships lie in the critical
involvement of the microbiome in calorie recovery through
further processing of dietary nutrients and indigestible ﬁbers.
Levels of leucine and isoleucine were reduced together with
their keto-acid derivative (a-keto-isocaproate) in L. paracasei-
supplemented mice. These observations suggest higher
catabolism of branched-chain amino acids to produce acetyl-
CoA and glucose via gluconeogenesis. Decreased levels of
citrateinurineandplasma,but increasedliversuccinate levels
may also indicate the shunt of the tricarboxylic acid cycle
towards production of phosphoenolpyruvate for gluconeogen-
esis in L. paracasei-supplemented mice. Moreover, reduction
of liver glycogen observed with L. paracasei supplementation
is consistent with our other observations of generalized host
mobilization of other metabolic fuels.
Probiotics induce speciﬁc microbiome–host
transgenomic metabolic interactions
We investigated the relationship between probiotic-induced
changes in gut microbes and bile acid cometabolism using
bipartite graphs to display correlation patterns between fecal
ﬂora and bile acids (Figure 5). Correlation analysis derived
from bile acid and fecal ﬂora proﬁles offers a unique approach
to capture subtle variations in bile acid composition that may
be directly related to changes in gut microbial levels, and that
may be induced by accumulation of bile acids in Lactobacillus
probiotics for instance. Control HBF mice and HBF mice
supplemented with probiotics show remarkably different bile
acid/fecal ﬂora correlation networks. The different bacterial
strains of Bacteroides, Clostridia, Streptococci and Lactobacilli
share similar abilities to deconjugate the hepatic tauro-
conjugated bile acids (Midtvedt and Norman, 1967; Floch,
2002). In that regard, the overwhelming contrast between the
balance of these bacteria on one hand, and conjugated bile
acids (TCDCA, TbMCA, TCA, TUDCA) and unconjugated bile
acids (CA, aMCA, bMCA) on the other hand, highlights the
metabolic ﬂexibility of the gut microbiota in response to
probiotics supplementation. These different correlative pat-
terns further characterize the microbial–mammalian transge-
nomic metabolic interactions, whereby probiotics-induced
modulation of the gut microbial functional ecosystem results
in different bile acid composition (Figure 2) and enterohepatic
recirculation.
The relationship between speciﬁc gut microbial strains and
bile acid cometabolism is well illustrated with the contrast
between Lactobacillus, which shows resistance to bile salt
toxicity (Corcoran et al, 2005), and C. perfringens, which is
sensitive to the strong growth inhibitory effects of unconju-
gated bile acids and TCDCA (Kishinaka et al, 1994; Floch,
2002). In the absence of Lactobacillus supplementation,
C. perfringens has anticorrelated connections with TCDCA,
aMCA and bMCA, which highlights the strong inhibitory
effects of these bile acids on C. perfringens growth. Interest-
ingly, the probiotic supplementation was either associated
with maintenance or decrease of the Clostridial population
(Table I), while no functional correlations between
C. perfringens and bile acids were observed. In that regard,
these observations may indicate different nutritional competi-
tion leading to modulation of C. perfringens population and
maintainance of the intestinal ecology. Consequently, inter-
bacterial cooperation to transform bile acids is an important
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of microbial balance but also to modulate dietary fat
emulsiﬁcation and absorption.
Gut-bacterial production of methylamines via
choline metabolism
The elevation of methylamines (TMA, TMAO) in liver, choline
and GPC in the plasma and decreased choline in feces from
HBF mice supplemented with L. rhamnosus (Figure 1) are
additional illustrations of the complex ‘microbial–mammalian
metabolic axis,’ as the microbiota are involved in the synthesis
and metabolism of these methylamines (al-Waiz et al, 1992).
The ﬁrst reaction of the methylamine pathway involves
conversion of dietary choline into TMA by gut microbiota
(Zeisel et al, 1983), which is then detoxiﬁed to TMAO in the
livervia the ﬂavine monooxygenase system (Smith et al, 1994;
(Figure 6). L. rhamnosus supplementation contributes to
higher absorption of free choline and may induce elevated
production of methylamines by Bacteroides and C. perfringens
(Allison and Macfarlane, 1989) through nutritional com-
petition.
Interestingly, L. paracasei consumption may favor a
different metabolic fate for choline through different bacterial
reprocessing. Decreased fecal choline was associated with
reduced concentrations of TMA and DMA in the liver, an
increase in plasma GPC, but with no changes in liver TMAO
and plasma choline after L. paracasei supplementation. These
animals also showed a greater reduction in plasma lipopro-
teins when compared to other groups. Here, these observa-
tions may result from elevated bacterial consumption for
cholesterol assimilation (Rasic, 1992) and phospholipid
metabolism (Jenkins and Courtney, 2003; Taranto et al,
2003; Kankaanpaa et al, 2004). Thus, the reduced availability
of choline to other bacterial strains may have led to lower
production of methylamines and absorption of free choline
into host metabolism.
Probiotic modulation of amino-acid metabolism
Investigation of the urine metabolic proﬁles showed signiﬁ-
cant increases in the concentrations of microbial cometabo-
lites PAG, IAG and tryptamine in probiotic supplemented mice
(Goodwin et al, 1994; Smith and Macfarlane, 1996). These
metabolites are produced from amino acids, which after
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Figure 6 Gut-microbiota–mammalian cometabolism of methylamines and aromatic amino acids. DMG, dimethylglycine; IA, indoleacetate; MA, methylamine;
PA, phenylacetate (see Figure 1).
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endopeptidases and bacterial proteases and peptidases,
become available for fermentation by the gut microﬂora
(Smith and Macfarlane, 1996), as outlined in Figure 6.
Metabolism of the aromatic amino acids phenylalanine,
tyrosine and tryptophan generates phenylacetate (PA),
p-cresol, indoleacetate (IA) and tryptamine, respectively
(Donaldson, 1962; Smith and Macfarlane, 1996). PA and IA
may be detoxiﬁed in the gut mucosa and the liver by glycine
conjugation forming PAG and IAG prior to excretion via the
urine (Donaldson, 1962; Smith and Macfarlane, 1996). The
production of PA and IA has been restricted to a certain
taxonomic group of gut bacteria, including Bacteroides,
Clostridia and E. coli, which count among the dominant
species in HBF colonized mice (Smith and Macfarlane, 1996;
Xu et al, 2002). The increased urinary excretion of phenolic
and indolic compounds reﬂects variations in gut microﬂora
composition in relation to nutritional competition (Smith and
Macfarlane, 1996; Nowak and Libudzisz, 2006). For instance,
IA has been reported to inhibit the growth and survival of
Lactobacilli, and speciﬁcally L. paracasei (Nowak and
Libudzisz, 2006).
In addition, increased levels of lysine in feces from mice
supplemented with probiotics is another example of bacterial
contribution to the mammalian amino-acid homeostasis
(Metges, 2000) and hepatic protein synthesis (Metges et al,
2006; Figure1). Higher productionof bacterial isobutyrateand
isovalerate (TableII)suggests increased bacterial fermentation
of leucine and valine that can also inﬂuence host energy
metabolism (Macfarlane et al, 1992). Moreover, L. paracasei
supplementation speciﬁcally induced higher urinary excretion
of NAG and decreased N-acetylated metabolites in fecal
extracts. A relationship between high casein diet and
urinary excretion of NAG has been described previously
(Hallson et al, 1997), which also suggested elevated bacterial
proteolysis.
Altogether, our data suggest that the probiotic-induced
increased proteolytic activities may reﬂect the basal metabo-
lismoftheseLactobacillusstrains,inparticularL.paracaseifor
which the proteolytic activities on casein medium are known
to be elevated (Sasaki et al, 1995; Ikram and Mukhtar, 2006).
Moreover, increased urinary NAG levels have been reported as
a biomarker of increased tubular activity and tubular cell
toxicity. Changes in bacterial fermentation of carbohydrates
can lead to different ion absorption from the gut (Scholz-
Ahrens et al, 2001), which may contribute to altered kidney
metabolism and tubular activity. Therefore, the gut microbial
contribution to the modulation of the NAG biomarker is
certainly of potential toxicological assessment signiﬁcance.
H-PCA modelled multicompartmental matrices
related to lipid metabolism
H-PCA has been explored for the ﬁrst time as a top-down
systems approach to model and integrate metabolic proﬁles
from diverse biological compartments. H-PCA modelling
summarized clearly the intercorrelated changes induced by
probiotic-treatment in plasma, urine and liver matrices and
composition in bile acids (Figure 4). One beneﬁt of the
hierarchical approach lies in the much simpliﬁed simulta-
neous visualization of global system biochemical changes in
multibiological matrices and improves interpretability. For
instance, H-PCA resulted in a separation between the treated
groups, which was not observed in separate PCA models. In
addition, the H-PCA loadings plot gives the relative impor-
tance of the different blocks (biological matrices) in carrying
diet-induced discriminantinformation.Moreover,therelation-
ships between the descriptors in the simpliﬁed H-PCA space
(H-PCA loadings plot) indicate correlations and anticorrela-
tions between block variables, which may give insight into
correlations between the metabolic variations in different
biological matrices as exempliﬁed here by metabolic changes
in liver, plasma and urine and related to lipid metabolism. The
H-PCA model also efﬁciently summarized the intercorrelated
changes related to higher systemic glycolysis in plasma, urine
and liver matrices, that is, reduced ketone body formation,
anaerobic glycolysis, tricarboxylic cycle perturbation and
amino-acid catabolism (Figure 4). Such observations might
lead to better description of multiorgan metabolic perturba-
tions (Figure 4B). This multicompartmental top-down
approach offers a way forward to study the systemic
biochemical proﬁles and regulation of function in whole
organisms by analyzing simultaneously several metabolite
pools from different bioﬂuids and tissues. This approach also
provides a new strategy for the quantitative and qualitative
evaluation of different probiotic (or indeed any functional
food or nutriceutical) interventions in relation to host
biochemistry.
Conclusion
Signiﬁcant associations between host metabolic phenotypes
and a nutritionally modiﬁed gut-microbiota strongly supports
the idea that changes across a whole range of metabolic
pathways are the product of extended genome perturbations
that can be oriented using probiotic supplementation, and
which may play a role in host metabolic health. Bipartite
network analysis highlights the metabolic ﬂexibility of the gut
microbiota, whereby bacterial strains communicate with each
other to metabolize differently bile acids in a gut microbial
ecosystem modulated with probiotics. In this case, probiotic
consumption exerted a modiﬁcation over the microbiome
resulting in different hepatic inﬂux and efﬂux of fatty acids in
theliver,asobservedwith increasedenterohepaticrecyclingof
bile acids and dietary fats, lowered plasma lipoprotein levels
and stimulated glycolysis. Probiotics also induced a different
microbial proteolytic activity as well as modulation of
bacterial metabolism of amino acids, methylamines and
SCFAs. We showed the novel application of H-PCA as a means
to study perturbation of metabolic proﬁles triggered by
symbiotic microbiota at a ‘global system’ level by analyzing
several metabolite pools simultaneously from different bio-
ﬂuids and tissues. These integrated system investigations
demonstrate the potential of metabolic proﬁling as a top-down
systems biology driver for investigating the mechanistic basis
of probiotic action and the therapeutic surveillance of the gut
microbial activity related to dietary supplementation of
probiotics and their health consequences.
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Animal handling procedure
All animal studies were carried out under appropriate national
guidelines at the Nestle ´ Research Center (Lausanne, Switzerland).
The HBF is constituted of a total of seven bacterial strains, isolated
fromstoolofa20-day-oldfemalebabythatwasnaturallydeliveredand
breast-fed, namely E. coli, B. breve and B. longum, S. epidermidis and
S. aureus, C. perfringens and Bacteroides distasonis. Bacterial cell
mixtures contain approximately 10
10 cells/ml for each strain and were
kept in frozen aliquots until use. Lactobacillus paracasei NCC2461 and
L. rhamnosus NCC4007 probiotics were obtained from the Nestle ´
Culture Collection (Lausanne, Switzerland).
A total of 28 female germ-free mice (C3H strain), aged 6 weeks,
received a single dose of HBF bacteria mixture and will be called HBF
mice in the current manuscript. The experimental design is detailed in
Supplementary Figure 2. The animals were fed with a standard
pathogen-free rodent diet constituted of 50% cornstarch, 20% casein,
10% sucrose, 7% soybean oil, 5% cellulose, 0.25% choline bitartrate,
0.3%cystineandvitaminandmineralmixtures(Reevesetal,1993)for
2 weeks. A control group of HBF mice (n¼10) received a saline drink
ad libitum containingMan, Rogosa andSharpe (MRS) culture medium
and was fed with a basal mix diet containing in composition 2.5% of a
glucose–lactose mixture (1.25% each) for 2 additional weeks. Two
groups of HBF mice were given a daily probiotic supplement, either
L. paracasei (group A, n¼9) or L. rhamnosus (group D, n¼9),
containing around 10
8 probiotic bacteria in MRS per day mixed with
thesalinesolutionadlibitumandwerealsofedwiththebasalmixdiet.
Fecal pellets were ﬁrst collected in the morning for microbiological
analysis and frozen at  801C for NMR spectroscopic analysis. Urine
was then collected from animals prior to euthanasia and frozen at
 801C. Urine samples were not obtained for every animal, as some
mice had an empty bladder at the time of killing (group A, n¼8; group
B, n¼6; group C, n¼8). Blood (400ml) was collected into Li-heparin
tubes and plasma was obtained after centrifugation and frozen at
 801C. The ileum and liver were dissected and snap-frozen. Ileal ﬂush
samples were obtained by rinsing the ileal lumen using a 1ml sterile
syringe containing a phosphate buffer solution (0.2M Na2HPO4/
0.04M NaH2PO4, pH 7.4) for UPLC-MS analysis. Cecal content was
collected upon animal autopsy, snap-frozen immediately and main-
tained at  801C prior to analysis.
Microbial proﬁling of fecal contents
Immediately after collection, fecal pellets were homogenized in 0.5ml
Ringer solution (Oxoid, UK) supplemented with 0.05% (w/v)
L-Cystein (HCl). The enumeration of speciﬁc microorganisms was
performed after plating and incubation of different dilutions of the
bacterial solution on selective and semiselective media, for example,
Biﬁdobacteria on Eugom Tomato medium, Lactobacillus on
MRSþantibiotic (phosphomycine, sulfamethoxazole, trimethoprim)
medium, C. perfringens on NN-agar medium, Enterobacteriaceae on
Drigalski medium and Bacteroides on Shaedler Neo Vanco medium.
Enterobacteriaceae cultures were incubated at 371C under aerobic
conditionsfor24h,andothercultureswereincubatedunderanaerobic
conditions over a 48h period.
Gas-chromatography on cecal content
Analiquotofcecalcontentwasextractedwith4mlbuffer(0.1%(w/v)
HgCl2 and 1% (v/v) H3PO4 supplemented with 0.045mg/ml 2,2-
dimethylbutyricacid (as internalstandard) pergram fresh weight. The
resulting slurry was centrifuged for 30min at 5000g at 41C. Fecal
SCFAs were analyzed using a gas-chromatograph (HP 6890) equipped
with a ﬂame ionization detector and a DB-FFAP column (J&W
Scientiﬁc, MSP Friedli & Co, Switzerland) of 30m length, 530mm
diameterand1mmﬁlmthickness.Thesystemwasrunwithheliumgas
at an inlet constant pressure of 10psi at 1801C. Each sample run was
preceded with a cleaning injection of 1.2% formic acid. Samples were
run at an initial temperature of 801C for 1.2min followed by heating to
1451C in 6.5min, heating to 2001C in 0.55min and an additional
0.5min at 2001C. SCFAs were identiﬁed using external standards
(acetate, propionate, iso-butyrate, n-butyrate, iso-valerate, n-valerate)
and the concentration was calculated using the internal standard.
1H NMR spectroscopic analysis
A volume of 100ml of blood plasma was added to 450ml of saline
solution containing 10% D2O, which was used as a spectrometer ﬁeld
frequency lock, into 5mm NMR tubes. Urine samples were prepared
by mixing 20ml of samples with 30ml of a phosphate buffer solution
containing 90% D2O and 0.25mM 3-trimethylsilyl-1-[2,2,3,3-
2H4]
propionate (TSP), which was used as chemical shift reference (d 0.0),
into 1.7mm NMR tubes. Fecal pellets were homogenized in 650mlo fa
phosphate buffer solution containing 90% D2O and 0.25mM TSP. The
fecalsamplesweresonicatedfor30minat251Candthencentrifugedat
13000r.p.m. for 20minto removeparticulates. The supernatants were
removedandcentrifugedat13000r.p.m.for10min.A580mlaliquotof
the fecal supernatant was then pipetted into a 5mm NMR tube for
spectroscopic analysis.Portions of intact liversamples(B15mg) were
bathed in ice-cold 0.9% saline D2O solution and packed into a
zirconium oxide 4mm outer diameter rotor.
1H NMR spectra were acquired for each sample using a Bruker DRX
600 NMR spectrometer (Rheinstetten, Germany) operating at
600.11MHz for
1H. The instrument was equipped with a Bruker
5mm TXI triple resonance probe maintained at 298K for liquid
samples and a standard Bruker high-resolution MAS probe under
magic-angle-spinning conditions at a spin rate of 5000Hz for intact
tissues (Waters et al, 2000). Tissue samples were regulated at 283K to
minimize biochemical degradation.
One-dimensional (1D)
1H NMR spectra were obtained from each
sample using a standard solvent suppression pulse sequence (RD-901-
t1-901-tm-901-acquire FID) with tm ﬁxed at 100ms and t1 at 3ms (Wang
et al, 2005). Additional spin echo Carr-Purcell-Meiboom-Gill (CPMG)
spectra were acquired for plasma and liver samples using the pulse
sequence(RD-901-(t-1801-t)n-acquireFID),withaspin–spinrelaxation
delay, 2nt, of 160ms for plasma and 200ms for tissue (Meiboom and
Gill, 1958). The 901 pulse length was 9.0–12ms. A total of 128
transientswerecollectedinto32Kdatapointswitharecycledelay(RD)
of 2s. The assignment of the
1H NMR spectral peaks to speciﬁc
metabolites was achieved based on the literature (Nicholson et al,
1995; Fan, 1996), and conﬁrmed by 2D COrrelation SpectroscopY
(COSY) (Hurd, 1990) and TOtal Correlation SpectroscopY (TOCSY)
(Bax and Davis, 1985). 2D NMR spectra were acquired on selected
samples.Furtherassignmentofthemetaboliteswasalsoaccomplished
withtheuseofStatisticalTOtalCorrelationSpectroscopY(STOCSY)on
1D spectra (Cloarec et al, 2005a).
UPLC-MS methods
The Ultra Performancet liquid chromatography of ileal ﬂushes was
performed on a ACQUITY UPLC system (Waters, Milford, MA, USA)
equipped with a Toft LCT-Premier (Waters MS Technologies,
Manchester, UK) for mass detection using the method we described
previously (Martin et al, 2007a). The same conditions were applied for
analysis of the following bile acid standards: cholic (CA), taurocholic
(TCA), glycocholic (GCA), deoxycholic (DCA), taurodeoxycholic
(TDCA), glycodeoxycholic (GDCA), chenodeoxycholic (CDCA), taur-
ochenodeoxycholic (TCDCA), glycochenodeoxycholic (GCDCA),
lithocholic (LCA), taurolithocholic (TLCA), glycolithocholic (GLCA),
ursodeoxycholic (UDCA), tauroursodeoxycholic (TUDCA), glycourso-
deoxycholic (GUDCA), hyocholic (HCA), a-muricholic (aMCA),
b-muricholic (bMCA), o-muricholic (oMCA), tauro-b-muricholic
(TbMCA) and tauro-a-muricholic (TaMCA) acids. We have previously
given the molecular structure, the retention time and the mass to
charge ratio (and not the molecular weight as published previously) of
the observed ions. Unconjugated bile acids formed a formate adduct.
Data analysis
Microbial counts and SCFAs composition in the cecum were analyzed
using a two-tailed Mann–Whitney test.
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distortion and referenced to the chemical shift of the CH3 resonance of
alanine at d 1.466 for plasma and liver samples, to the TSP resonance
of alanine at d 0.0 for urine and fecal samples using XwinNMR 3.5
(Bruker Biospin, Rheinstetten, Germany). The spectra were converted
into 22K data points over the range of d 0.2–10.0 using an in-house
developed MATLAB routine. The regions containing the water
resonance (d 4.5–5.19), and for urine urea resonance (d 4.5–6.2),
were removed. Chemical shift intensities were normalized to the sum
of all intensities within the speciﬁed range before chemometric
analysis.
UPLC-MS data were processed using the Micromass MarkerLynxt
applications manager Version 4.0 (Waters Corp, Milford, USA). The
peaks of bile acids were identiﬁed by comparing the m/z ratio and
retention time to the set of standard bile acids measured under the
same conditions. Datawere noise-reduced in both of the UPLC and MS
domains using MarkerLynx standard routines. Integration of the
UPLC-MS bile acid peaks was performed using ApexTrack2t. Each
peak integral was expressed as a ratio to the sum of integrals of the 21
measured bile acids.
The multivariate pattern recognition techniques used in this study
were based on PCA (Wold et al, 1987), H-PCA (Westerhuis et al, 1998)
and the orthogonal-projection to latent structure (O-PLS) (Trygg and
Wold, 2003). PCA was carried out using the SIMCA-P 11 software
(Umetrics, Umea ˚, Sweden) in order to detect the presence of inherent
similarities between metabolic proﬁles. Both NMR and LC-MS
variables were subjected to Pareto scaling, by dividing each variable
by the square root of its standard deviation. Data were visualized by
meansofprincipal component scoresandloadings plots. Eachpoint in
the scores plot represents an individual biochemical proﬁle of a
sample, whereas on the loadings plot each coordinate represents a
single NMR spectral region or LC-MS retention time and mass to
charge ratio (m/z). Because the scores and loadings plots are
complementary, biochemical components responsible for the differ-
ences between samples detected in the scores plot can be extracted
from the corresponding loadings plot.
O-PLS-DAwasalsocarriedoutusingthemethoddevelopedbyTrygg
et al (Trygg and Wold, 2003) and implemented for NMR spectral data
by Cloarec et al (2005b) to exclusively focus on the effects of probiotic
supplementation. All O-PLS-DA models were constructed using one
predictive and two orthogonal components using data scaled to unit
variance (i.e. by dividing each variable by its standard deviation).
Here, the test for the signiﬁcance of the Pearson product–moment
correlation coefﬁcient was used to calculate the cut-off value of the
correlation coefﬁcients at the level of Po0.05. To test the validity of
the model against over-ﬁtting, the cross-validation parameter Q
2
was computed and the standard seven-fold cross validation method
was used (Cloarec et al, 2005b). The interpretation of the model was
achieved from correlation coefﬁcient plots that incorporated a back-
transformation method such that the coefﬁcients resembled the
original structure of the NMR spectral data (Cloarec et al, 2005b).
H-PCA methods have been proposed in the recent literature to
improve the interpretability of multiple models (Westerhuis et al,
1998) generated from several blocks of descriptor variables measured
on the same objects (Bergman et al, 1998; Lundstedt et al, 1998; Janne
et al, 2001). The data are divided into well-deﬁned logical blocks X1,
y,X B (where the index B refers to each biosample type), according to
an event, instrumentation or biological compartment. A consensus
direction among all the blocks is sought. Here, logical blocks were
deﬁned according to the biological nature of the samples obtained
from the same animals (Figure 3). Hence, ﬁve independent blocks of
variables were comprised of NMR data from plasma, liver, urine and
fecal extracts as well as bile acids composition obtained by UPLC-MS.
PCA was performed on each data matrix individually, and block
loadings pb and scores tb were generated for each block (Figure 3). All
block scores tb were then combined into a super block T. The PCA (H-
PCA)wasthenappliedtothesuperblockTtogeneratethesuperscores
tTandthesuperloadingspT.ThesuperscorestT givesthe relationships
between the observations and all the sources of variations. The
super loadings pT gives the relative importance of the different blocks
XB for each principal component as well as information on the
relationship/covariancebetweenthedifferentvariablesinthedifferent
compartments.
Bipartite graph representation of bile acid and
fecal ﬂora proﬁles
The bipartite graph (Rgraphsviz) package from R was used to display
the correlation matrix derived from bile acid and fecal ﬂora proﬁles to
assess the probiotic-induced changes to the microbial-mammalian
transgenomic interactions (Figure 5). Pearson’s correlation coefﬁ-
cients were computed between bile acid variables and fecal ﬂora
variables from the same mice and a cut-off value of 0.5 was applied to
the absolute value of the coefﬁcient |r| so that the bipartite graph only
represents the correlations between the two types of nodes (fecal ﬂora
and bile acids) above the cut-off (Martin et al, 2007a). The sign of the
initial correlation was then color coded (red: negative, blue: positive),
and the correlation value displayed on the bipartite graph. In that
context, presence of edges between two speciﬁc nodes (one of each
type)revealsafunctionalcorrelation(abovethecut-off)betweenthese
entities.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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